CAT and cancer: An oxygen-generating implantable material consisting of alginate beads encapsulating CaO2 and catalase has been developed by Huang and colleagues [138] as an active carrier for doxorubicin, with the aim to increase the drug sensitivity in cancer cells undergoing hypoxia-induced chemo-resistance.